Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2018

View Archived Issues

CRISPR reprograms T cells

Good-enough HCV vaccine could reduce transmission

BAFF and Beffs

Hot flashes are hypothalamic

Hearing light, no synesthesia required

ONO-8590580, a GABA(A)-alpha5 negative allosteric modulator enhancing hippocampal memory function

Novel CD-1db/db mouse model of type 2 diabetes with progressive kidney fibrosis

Discovery of novel PET tracer for imaging CSF-1R in the brain

First cohort dosed in phase I study of OMS-527

Blade Therapeutics initiates phase I study of BLD-2660

Cellectar reports 94% reduction in tumor volume in patient

Regeneron initiates phase I study of REGN-4659 plus cemiplimab in patients with NSCLC

Enrollment ongoing in phase II study of F-901318

Reactivated X chromosome produces functional Rett protein in mouse brains

Chinese researchers present preclinical data for DB-213, an HIV-1 replication inhibitor

Capricor Therapeutics' CAP-2003 to be studied for potential for trauma-related injuries

Voyager's VY-AADC program in Parkinson's guided by FDA and new phase I posterior trajectory data

FDA approves Symtuza for HIV-1 infection

Phase Ib results support Poxel's plans for phase II with PXL-770 in NASH

Roche and C4 Therapeutics patent EGFR mutant inhibitors

Pulmatrix reports data from Part 3 of first-in-human study of Pulmazole

Ono Pharmaceutical synthesizes PTK6 inhibitors

Italian researchers identify compounds for kinetoplastid infections

Oligomerix presents tau aggregation inhibitors

Merck & Co. divulges FFA1 receptor agonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...